Who
Carlo Sistilli
Director
Company insider
Files Form 4 as: Director, Edesa Biotech.
In numbers
- Trades disclosed
- 18
- Buys
- 1
- Sells
- 0
- Bought
- $10K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 8 Jan 2020
- Last trade
- 27 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 May 2026filed 29 May 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 27 May 2026filed 29 May 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —20,001 at $0.00 | filing |
| 12 Feb 2025filed 14 Feb 2025 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | $20K10,416 at $1.92 | filing |
| 20 Jul 2023filed 24 Jul 2023 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 20 Jul 2023filed 21 Jul 2023 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 28 Feb 2022filed 7 Mar 2022 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 22 Apr 2021filed 26 Apr 2021 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 5 Nov 2020filed 6 Nov 2020 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code X | —1,218 at $0.00 | filing |
| 5 Nov 2020filed 6 Nov 2020 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code X | $4,8721,218 at $4.00 | filing |
| 13 Oct 2020filed 14 Oct 2020 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 12 Feb 2020filed 14 Feb 2020 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,389 at $0.00 | filing |
| 8 Jan 2020filed 13 Jan 2020 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,827 | filing |
| 8 Jan 2020filed 13 Jan 2020 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,218 | filing |
| 8 Jan 2020filed 13 Jan 2020 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | $10K2,436 at $4.11 | filing |
| 8 Jan 2020filed 10 Jan 2020 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code P | —1,827 | filing |
| 8 Jan 2020filed 10 Jan 2020 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code P | —1,218 | filing |
| 8 Jan 2020filed 10 Jan 2020 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $10K2,436 at $4.11 | filing |
News
Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo StudyEDSA · elliotlakestandard.ca · 15 Oct 2026Edesa Biotech (NASDAQ:EDSA) Stock Falls 16.2% – Time to Sell?EDSA · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name Carlo Sistilli; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.